Its influences on improving hepatic failure are achieved via the declined serum contents of alanine aminotransferase and aspartate aminotransferase in mice and the inhibition of toll-like receptor 4 (TLR4)/MAPK or TLR4/NF-κB in macrophages [20]. Here, TLR4 is linked to Hepatic failure.